Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Pancreatic Ductal Adenocarcinoma”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Not applicableStudy completedNCT06344299
What this trial is testing

Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 5,302
Not applicableLooking for participantsNCT06574620
What this trial is testing

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma+1 more
British Columbia Cancer Agency 200
Testing effectiveness (Phase 2)Study completedNCT02178709
What this trial is testing

A Phase II Study of Neoadjuvant FOLFIRINOX

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma
Indiana University 48
Testing effectiveness (Phase 2)Study completedNCT03496662
What this trial is testing

BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Washington University School of Medicine 40
Testing effectiveness (Phase 2)Ended earlyNCT04176952
What this trial is testing

PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Neoplasms Pancreatic
Judith Dixon-Hughes 31
Not applicableUnknownNCT04164992
What this trial is testing

Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) of Not-resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Campus Bio-Medico University 15
Testing effectiveness (Phase 2)WithdrawnNCT03908333
What this trial is testing

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Medical College of Wisconsin
Not applicableUnknownNCT04855331
What this trial is testing

Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC

Who this might be right for
Borderline Resectable Pancreatic Cancer
Fudan University 120
Early research (Phase 1)Ended earlyNCT02782182
What this trial is testing

Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of Chicago 1
Not applicableLooking for participantsNCT07157605
What this trial is testing

Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

Who this might be right for
Pancreatic Cancer ResectablePancreatectomy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT04481204
What this trial is testing

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center 105
Early research (Phase 1)Study completedNCT00985777
What this trial is testing

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

Who this might be right for
Pancreatic Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 26
Early research (Phase 1)Active Not RecruitingNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Large-scale testing (Phase 3)Looking for participantsNCT07252232
What this trial is testing

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic CancerPDACPDAC - Pancreatic Ductal Adenocarcinoma+2 more
Revolution Medicines, Inc. 500
Large-scale testing (Phase 3)Looking for participantsNCT04927780
What this trial is testing

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaResectable Pancreatic Adenocarcinoma
Erasmus Medical Center 378
Early research (Phase 1)Not Yet RecruitingNCT06913218
What this trial is testing

MRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

Who this might be right for
Pancreas CancerPancreas Cancer, Duct Cell Adenocarcinoma
Akeso 60
Testing effectiveness (Phase 2)Looking for participantsNCT06060405
What this trial is testing

Durvalumab and Oleclumab in Resectable PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Health Network, Toronto 22
Testing effectiveness (Phase 2)Looking for participantsNCT06821997
What this trial is testing

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT05132504
What this trial is testing

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Baylor College of Medicine 30
Not applicableStudy completedNCT05888129
What this trial is testing

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Postoperative Complications
Asan Medical Center 1
Load More Results